Delivery Order SPE2DB22D2211-SPE2DB25FSCCY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections at a firm fixed price of $37,100.84, with completion required by August 1, 2025. This competitive award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The order will be fulfilled from the company's corporate office location...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,360.72 for Zepbound 7.5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- On July 24, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $7,569.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive award executed under an existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,921.52 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,338.06 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections valued at $7,625.80 on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical supply delivery under a competitive procurement process, reflecting the agency's continued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,482.05 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order valued at $3,151.17 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract performance will take place at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,888.45 on July 30, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a firm fixed price transaction with an ultimate completion date of July 31, 2025. The contract does not include a set-aside designation and was competitively awarded. Performance will be executed from AmerisourceBergen's...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCCYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,842.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 4, 2025, with completion targeted for August 5, 2025. The contract utilized firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical devices to support military healthcare systems and other federal customers. The Zepbound supply supports DLA's mission to provide medical commodities to Defense Health Agency and other government healthcare entities, with the product representing part of the contractor's broader portfolio of specialty medications delivered through the prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 8/4/25 |